Monday, 15 July 2024

Catalent adds new cryogenic capabilities at Japan facility to support cell & gene therapy development

25 May 2023 | News

To provide the optimum logistical solution for every customer's individual needs

Catalent has expanded the services and capabilities at its facility in Shiga, Japan, to include the storage, kitting, and distribution of advanced therapies at ultra-low temperatures for clinical trials.

State-of-the-art cryogenic freezers alongside material transfer equipment have been installed that are designed to retain the integrity of investigational advanced therapy products by minimizing their time-out-of-environment. The expansion forms part of Catalent's ongoing global strategy to increase its ability to handle, store and manage advanced therapies for clinical supply, and follows investments at its facilities in PhiladelphiaSingapore, and Shanghai, China, in specialised, ultra-low temperature storage capabilities.

The 6,000-square-meter Shiga site opened in October 2021 to support customers both locally and globally, providing flexible clinical supply solutions, including primary packaging, Catalent's FastChain demand-led supply, white glove handling and logistics.

"The market in Japan for advanced therapies and new modalities continues to grow, along with the demand for companies such as Catalent that have the advanced infrastructure to handle the supply and distribution of these highly sensitive products, as well as the specialized expertise and comprehensive knowledge to manage these supply chains," commented Tadahiro Matsumura, Catalent's President of Japan

Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account